Why the study?
In India, warm and wet types of HF remain common and residual congestion at discharge is a significant concern, creating an urgent need for reliable, sensitive identification of residual and subclinical pulmonary congestion.
This review highlights the clinical utility of monitoring systems like CardioMEMS and ReDS for the early detection and surveillance of pulmonary congestion in heart failure patients, particularly from an Indian perspective.
Answers are grounded in this paper and cite their sources.
May support remote congestion monitoring in Indian HF care; leaves open need for local RCTs before adoption.
Early pulmonary congestion detection and surveillance in acute heart failure patients can prevent decompensation, minimize hospitalizations, and improve prognosis. In India, the warm and wet types of HF are still the most common types and residual congestion at discharge is still a significant concern. Thus, there is an urgent need for a reliable and sensitive means of identifying residual and subclinical congestion. Two such monitoring systems are available and approved by US FDA. These include CardioMEMS HF System (Abbott, Sylmar, California) and ReDS System (Sensible Medical Innovations, Ltd., Nanya, Israel). CardioMEMS is a wireless pressure-sensitive implantable device, while ReDS is a wearable noninvasive device for measurement of the lung fluid and hence direct detection of PC. This review discusses the role of noninvasive assessment in PC monitoring in patients with heart failure and its implications from an Indian perspective.
No takes yet. Share an insight, caveat, or question.
Deora et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: